Acetylsalicylic acid Active Not Recruiting Phase 2 Trials for Barrett Esophagus-Negative for Dysplasia / Dysplasia in Barrett Esophagus / Esophagus, Barrett Prevention

IndicationsStatusPurposePhase
Active Not RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT02521285Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation